ASIC Regulatory Guide 25 allows a final offer statement to have a qualification attached.
In this case Pfizer has attached the qualification “subject to no competing proposal emerging”.
Takeovers Panel Has Been Contacted, page-10
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #